Health
Diabetes drug can treat and reverse heart failure and reduce – EurekAlert
Mount Sinai clinical trial results could help lead to FDA approval
Empagliflozin, a recently developed diabetes drug, can effectively treat and reverse heart failure in both diabetic and non-diabetic patients, according to researchers at the Icahn School of Medicine at Mount Sinai.
Their clinical trial showed that this medication can improve the heart’s size, shape, and function, leading to better exercise capacity and quality of life, which will reduce hospitalizations for heart failure patients. The results were presented on Friday, November 13, at the American…
-
Noosa News14 hours agoFlatmates of missing teen Pheobe Bishop, 17, identified
-
Noosa News16 hours agoTully Sugar Mill celebrates 100 years of cane harvesting amid floods and cyclones
-
General20 hours agoOne person dead after house fire in Melbourne’s south-east
-
General16 hours agoEmpire’s end • Inside Story